Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation

An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency

(2014) A. Marini et al.   JOURNAL OF IMMUNOLOGY

Human Immunodeficiency Virus Integrates Directly into Naive Resting CD4+ T Cells but Enters Naive Cells Less Efficiently than Memory Cells

(2009) J. Dai et al.   JOURNAL OF VIROLOGY

Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4+ T Cells

(2009) D. N. Vatakis et al.   JOURNAL OF VIROLOGY

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

(2009) Nicolas Chomont et al.   NATURE MEDICINE

The Challenge of Finding a Cure for HIV Infection

(2009) D. D. Richman et al.   SCIENCE

Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells

(2008) A. Bosque et al.   BLOOD

Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis

(2008) Claudia Fila et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells

(2008) Shailesh K. Choudhary et al.   JOURNAL OF INFECTIOUS DISEASES

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

(2008) Lin Shen et al.   NATURE MEDICINE

Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection

(2007) Luc Geeraert et al.   Annual Review of Medicine